...
首页> 外文期刊>Journal of proteome research >Histone H4 N-terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid-urea polyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometry.
【24h】

Histone H4 N-terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid-urea polyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometry.

机译:通过乙酸肽-尿素聚丙烯酰胺凝胶电泳,氨基酸编码的质量标记和质谱测定的用去肽肽处理的Kasumi-1细胞中的组蛋白H4 N末端乙酰化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Disrupted patterns of acetylation and deacetylation of core histones play an important role in silencing transcription of hematopoietic important genes in acute myeloid leukemia (AML). A thorough investigation of these mechanisms and the response to pharmacologic modifiers will provide a better understanding of the role of histone acetylation in leukemogenesis. We describe here an analytical approach that combines acid urea polyacrylamide gel electrophoresis (AU-PAGE), amino acid coded mass tagging (AACM), and mass spectrometry (MS) for the investigation of histone acetylation patterns. The combined approach was used to follow the dynamics of H4 acetylation in Kasumi-1 cells harboring the fusion gene AML1/ETO shown to aberrantly recruit histone deacetylases (HDACs). The histones in Kasumi-1 cells were labeled by growing the cells in media in which lysine was replaced with stable isotope-labeled lysine (Lys-D4). Labeled and unlabeled cells were treated with depsipeptide and analyzed at different time points (0, 4, 8, 12, 24, and 48 h). The cells were mixed, the histone was extracted, and acetylated H4 isoforms were separated using AU-PAGE before in-gel trypsin digestion. The digests were analyzed by MALDI-TOF MS. Peptides were identified by mass and isotope pattern. LC-MS/MS of Arg-C digests were also performed to verify the acetylation pattern for H4. The major pattern of acetylation was determined as follows: initial acetylation at K16, followed by acetylation at K12, and finally acetylation of either K8 and/or K5.
机译:核心组蛋白乙酰化和脱乙酰化的中断模式在沉默急性髓细胞性白血病(AML)中造血重要基因的转录沉默中起重要作用。对这些机制和对药理学修饰剂的反应的深入研究将使人们更好地了解组蛋白乙酰化在白血病发生中的作用。我们在这里描述了一种结合酸性尿素聚丙烯酰胺凝胶电泳(AU-PAGE),氨基酸编码的质谱标记(AACM)和质谱(MS)的分析方法,用于研究组蛋白乙酰化模式。组合的方法用于跟踪具有融合基因AML1 / ETO的Kasumi-1细胞中H4乙酰化的动力学,该融合基因显示异常招募组蛋白脱乙酰基酶(HDAC)。 Kasumi-1细胞中的组蛋白是通过在赖氨酸被稳定的同位素标记的赖氨酸(Lys-D4)替代的培养基中生长来标记的。用去肽肽处理标记和未标记的细胞,并在不同的时间点(0、4、8、12、24和48 h)进行分析。混合细胞,提取组蛋白,并在凝胶内胰蛋白酶消化之前使用AU-PAGE分离乙酰化的H4亚型。通过MALDI-TOF MS分析消化物。通过质量和同位素模式鉴定肽。还进行了Arg-C消化液的LC-MS / MS验证H4的乙酰化模式。确定乙酰化的主要模式如下:在K16处开始乙酰化,然后在K12处乙酰化,最后在K8和/或K5处进行乙酰化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号